<?xml version="1.0" encoding="UTF-8"  standalone="no" ?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1997-11-01" modified="2024-10-02" version="193" xmlns="http://uniprot.org/uniprot">
  <accession>Q14444</accession>
  <accession>A6NMY7</accession>
  <accession>D3DR06</accession>
  <accession>Q15074</accession>
  <accession>Q6IMN4</accession>
  <accession>Q6IMN7</accession>
  <accession>Q9BV09</accession>
  <name>CAPR1_HUMAN</name>
  <protein>
    <recommendedName>
      <fullName evidence="26">Caprin-1</fullName>
    </recommendedName>
    <alternativeName>
      <fullName>Cell cycle-associated protein 1</fullName>
    </alternativeName>
    <alternativeName>
      <fullName>Cytoplasmic activation- and proliferation-associated protein 1</fullName>
    </alternativeName>
    <alternativeName>
      <fullName>GPI-anchored membrane protein 1</fullName>
    </alternativeName>
    <alternativeName>
      <fullName evidence="28">GPI-anchored protein p137</fullName>
      <shortName evidence="28">GPI-p137</shortName>
      <shortName evidence="28">p137GPI</shortName>
    </alternativeName>
    <alternativeName>
      <fullName>Membrane component chromosome 11 surface marker 1</fullName>
    </alternativeName>
    <alternativeName>
      <fullName>RNA granule protein 105</fullName>
    </alternativeName>
  </protein>
  <gene>
    <name evidence="27 31" type="primary">CAPRIN1</name>
    <name type="synonym">GPIAP1</name>
    <name type="synonym">GPIP137</name>
    <name type="synonym">M11S1</name>
    <name type="synonym">RNG105</name>
  </gene>
  <organism>
    <name type="scientific">Homo sapiens</name>
    <name type="common">Human</name>
    <dbReference type="NCBI Taxonomy" id="9606"/>
    <lineage>
      <taxon>Eukaryota</taxon>
      <taxon>Metazoa</taxon>
      <taxon>Chordata</taxon>
      <taxon>Craniata</taxon>
      <taxon>Vertebrata</taxon>
      <taxon>Euteleostomi</taxon>
      <taxon>Mammalia</taxon>
      <taxon>Eutheria</taxon>
      <taxon>Euarchontoglires</taxon>
      <taxon>Primates</taxon>
      <taxon>Haplorrhini</taxon>
      <taxon>Catarrhini</taxon>
      <taxon>Hominidae</taxon>
      <taxon>Homo</taxon>
    </lineage>
  </organism>
  <reference key="1">
    <citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="20717" last="20723">
      <title>Identification and characterization of a novel protein (p137) which transcytoses bidirectionally in Caco-2 cells.</title>
      <authorList>
        <person name="Ellis J.A."/>
        <person name="Luzio J.P."/>
      </authorList>
      <dbReference type="PubMed" id="7657653"/>
      <dbReference type="DOI" id="10.1074/jbc.270.35.20717"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
    <scope>TISSUE SPECIFICITY</scope>
    <scope>VARIANT ASP-263</scope>
    <source>
      <tissue>Colon</tissue>
    </source>
  </reference>
  <reference key="2">
    <citation type="journal article" date="2006" name="Nature" volume="440" first="497" last="500">
      <title>Human chromosome 11 DNA sequence and analysis including novel gene identification.</title>
      <authorList>
        <person name="Taylor T.D."/>
        <person name="Noguchi H."/>
        <person name="Totoki Y."/>
        <person name="Toyoda A."/>
        <person name="Kuroki Y."/>
        <person name="Dewar K."/>
        <person name="Lloyd C."/>
        <person name="Itoh T."/>
        <person name="Takeda T."/>
        <person name="Kim D.-W."/>
        <person name="She X."/>
        <person name="Barlow K.F."/>
        <person name="Bloom T."/>
        <person name="Bruford E."/>
        <person name="Chang J.L."/>
        <person name="Cuomo C.A."/>
        <person name="Eichler E."/>
        <person name="FitzGerald M.G."/>
        <person name="Jaffe D.B."/>
        <person name="LaButti K."/>
        <person name="Nicol R."/>
        <person name="Park H.-S."/>
        <person name="Seaman C."/>
        <person name="Sougnez C."/>
        <person name="Yang X."/>
        <person name="Zimmer A.R."/>
        <person name="Zody M.C."/>
        <person name="Birren B.W."/>
        <person name="Nusbaum C."/>
        <person name="Fujiyama A."/>
        <person name="Hattori M."/>
        <person name="Rogers J."/>
        <person name="Lander E.S."/>
        <person name="Sakaki Y."/>
      </authorList>
      <dbReference type="PubMed" id="16554811"/>
      <dbReference type="DOI" id="10.1038/nature04632"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="3">
    <citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
      <authorList>
        <person name="Mural R.J."/>
        <person name="Istrail S."/>
        <person name="Sutton G.G."/>
        <person name="Florea L."/>
        <person name="Halpern A.L."/>
        <person name="Mobarry C.M."/>
        <person name="Lippert R."/>
        <person name="Walenz B."/>
        <person name="Shatkay H."/>
        <person name="Dew I."/>
        <person name="Miller J.R."/>
        <person name="Flanigan M.J."/>
        <person name="Edwards N.J."/>
        <person name="Bolanos R."/>
        <person name="Fasulo D."/>
        <person name="Halldorsson B.V."/>
        <person name="Hannenhalli S."/>
        <person name="Turner R."/>
        <person name="Yooseph S."/>
        <person name="Lu F."/>
        <person name="Nusskern D.R."/>
        <person name="Shue B.C."/>
        <person name="Zheng X.H."/>
        <person name="Zhong F."/>
        <person name="Delcher A.L."/>
        <person name="Huson D.H."/>
        <person name="Kravitz S.A."/>
        <person name="Mouchard L."/>
        <person name="Reinert K."/>
        <person name="Remington K.A."/>
        <person name="Clark A.G."/>
        <person name="Waterman M.S."/>
        <person name="Eichler E.E."/>
        <person name="Adams M.D."/>
        <person name="Hunkapiller M.W."/>
        <person name="Myers E.W."/>
        <person name="Venter J.C."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="4">
    <citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
      <title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
      <authorList>
        <consortium name="The MGC Project Team"/>
      </authorList>
      <dbReference type="PubMed" id="15489334"/>
      <dbReference type="DOI" id="10.1101/gr.2596504"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
    <source>
      <tissue>Eye</tissue>
    </source>
  </reference>
  <reference key="5">
    <citation type="journal article" date="1996" name="Genomics" volume="32" first="169" last="170">
      <title>The gene encoding the GPI-anchored membrane protein p137GPI (M11S1) maps to human chromosome 11p13 and is highly conserved in the mouse.</title>
      <authorList>
        <person name="Gessler M."/>
        <person name="Klant B."/>
        <person name="Tsaoussidou S."/>
        <person name="Ellis J.A."/>
        <person name="Luzio J.P."/>
      </authorList>
      <dbReference type="PubMed" id="8786113"/>
      <dbReference type="DOI" id="10.1006/geno.1996.0099"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-72</scope>
  </reference>
  <reference key="6">
    <citation type="submission" date="2007-07" db="UniProtKB">
      <authorList>
        <person name="Bienvenut W.V."/>
        <person name="Heiserich L."/>
        <person name="Boulahbel H."/>
        <person name="Gottlieb E."/>
      </authorList>
    </citation>
    <scope>PROTEIN SEQUENCE OF 56-63; 88-110; 115-125; 148-158; 298-310 AND 634-660</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
    <source>
      <tissue>Colon carcinoma</tissue>
    </source>
  </reference>
  <reference key="7">
    <citation type="journal article" date="2004" name="J. Immunol." volume="172" first="2389" last="2400">
      <title>Activation/division of lymphocytes results in increased levels of cytoplasmic activation/proliferation-associated protein-1: prototype of a new family of proteins.</title>
      <authorList>
        <person name="Grill B."/>
        <person name="Wilson G.M."/>
        <person name="Zhang K.-X."/>
        <person name="Wang B."/>
        <person name="Doyonnas R."/>
        <person name="Quadroni M."/>
        <person name="Schrader J.W."/>
      </authorList>
      <dbReference type="PubMed" id="14764709"/>
      <dbReference type="DOI" id="10.4049/jimmunol.172.4.2389"/>
    </citation>
    <scope>IDENTIFICATION (ISOFORMS 1 AND 2)</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>MULTIMERIZATION</scope>
  </reference>
  <reference key="8">
    <citation type="journal article" date="2007" name="Mol. Cell. Biol." volume="27" first="2324" last="2342">
      <title>Distinct structural features of caprin-1 mediate its interaction with G3BP-1 and its induction of phosphorylation of eukaryotic translation initiation factor 2alpha, entry to cytoplasmic stress granules, and selective interaction with a subset of mRNAs.</title>
      <authorList>
        <person name="Solomon S."/>
        <person name="Xu Y."/>
        <person name="Wang B."/>
        <person name="David M.D."/>
        <person name="Schubert P."/>
        <person name="Kennedy D."/>
        <person name="Schrader J.W."/>
      </authorList>
      <dbReference type="PubMed" id="17210633"/>
      <dbReference type="DOI" id="10.1128/mcb.02300-06"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>INTERACTION WITH G3BP1</scope>
    <scope>MRNA-BINDING</scope>
    <scope>MUTAGENESIS OF ARG-612; ARG-633 AND ARG-690</scope>
  </reference>
  <reference key="9">
    <citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="24260" last="24269">
      <title>RNA granule protein 140 (RNG140), a paralog of RNG105 localized to distinct RNA granules in neuronal dendrites in the adult vertebrate brain.</title>
      <authorList>
        <person name="Shiina N."/>
        <person name="Tokunaga M."/>
      </authorList>
      <dbReference type="PubMed" id="20516077"/>
      <dbReference type="DOI" id="10.1074/jbc.m110.108944"/>
    </citation>
    <scope>IDENTIFICATION</scope>
  </reference>
  <reference key="10">
    <citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
      <title>A quantitative atlas of mitotic phosphorylation.</title>
      <authorList>
        <person name="Dephoure N."/>
        <person name="Zhou C."/>
        <person name="Villen J."/>
        <person name="Beausoleil S.A."/>
        <person name="Bakalarski C.E."/>
        <person name="Elledge S.J."/>
        <person name="Gygi S.P."/>
      </authorList>
      <dbReference type="PubMed" id="18669648"/>
      <dbReference type="DOI" id="10.1073/pnas.0805139105"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="11">
    <citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
      <title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
      <authorList>
        <person name="Olsen J.V."/>
        <person name="Vermeulen M."/>
        <person name="Santamaria A."/>
        <person name="Kumar C."/>
        <person name="Miller M.L."/>
        <person name="Jensen L.J."/>
        <person name="Gnad F."/>
        <person name="Cox J."/>
        <person name="Jensen T.S."/>
        <person name="Nigg E.A."/>
        <person name="Brunak S."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="20068231"/>
      <dbReference type="DOI" id="10.1126/scisignal.2000475"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="12">
    <citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
      <title>Initial characterization of the human central proteome.</title>
      <authorList>
        <person name="Burkard T.R."/>
        <person name="Planyavsky M."/>
        <person name="Kaupe I."/>
        <person name="Breitwieser F.P."/>
        <person name="Buerckstuemmer T."/>
        <person name="Bennett K.L."/>
        <person name="Superti-Furga G."/>
        <person name="Colinge J."/>
      </authorList>
      <dbReference type="PubMed" id="21269460"/>
      <dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="13">
    <citation type="journal article" date="2011" name="Hum. Mol. Genet." volume="20" first="4916" last="4931">
      <title>The X-chromosome-linked intellectual disability protein PQBP1 is a component of neuronal RNA granules and regulates the appearance of stress granules.</title>
      <authorList>
        <person name="Kunde S.A."/>
        <person name="Musante L."/>
        <person name="Grimme A."/>
        <person name="Fischer U."/>
        <person name="Mueller E."/>
        <person name="Wanker E.E."/>
        <person name="Kalscheuer V.M."/>
      </authorList>
      <dbReference type="PubMed" id="21933836"/>
      <dbReference type="DOI" id="10.1093/hmg/ddr430"/>
    </citation>
    <scope>INTERACTION WITH PQBP1</scope>
  </reference>
  <reference key="14">
    <citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
      <title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
      <authorList>
        <person name="Rigbolt K.T."/>
        <person name="Prokhorova T.A."/>
        <person name="Akimov V."/>
        <person name="Henningsen J."/>
        <person name="Johansen P.T."/>
        <person name="Kratchmarova I."/>
        <person name="Kassem M."/>
        <person name="Mann M."/>
        <person name="Olsen J.V."/>
        <person name="Blagoev B."/>
      </authorList>
      <dbReference type="PubMed" id="21406692"/>
      <dbReference type="DOI" id="10.1126/scisignal.2001570"/>
    </citation>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT PRO-2</scope>
    <scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="15">
    <citation type="journal article" date="2012" name="Biochim. Biophys. Acta" volume="1820" first="1839" last="1848">
      <title>Characterization of O-GlcNAc cycling and proteomic identification of differentially O-GlcNAcylated proteins during G1/S transition.</title>
      <authorList>
        <person name="Drougat L."/>
        <person name="Olivier-Van Stichelen S."/>
        <person name="Mortuaire M."/>
        <person name="Foulquier F."/>
        <person name="Lacoste A.S."/>
        <person name="Michalski J.C."/>
        <person name="Lefebvre T."/>
        <person name="Vercoutter-Edouart A.S."/>
      </authorList>
      <dbReference type="PubMed" id="22967762"/>
      <dbReference type="DOI" id="10.1016/j.bbagen.2012.08.024"/>
    </citation>
    <scope>GLYCOSYLATION</scope>
  </reference>
  <reference key="16">
    <citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
      <title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
      <authorList>
        <person name="Zhou H."/>
        <person name="Di Palma S."/>
        <person name="Preisinger C."/>
        <person name="Peng M."/>
        <person name="Polat A.N."/>
        <person name="Heck A.J."/>
        <person name="Mohammed S."/>
      </authorList>
      <dbReference type="PubMed" id="23186163"/>
      <dbReference type="DOI" id="10.1021/pr300630k"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-115</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="17">
    <citation type="journal article" date="2013" name="J. Virol." volume="87" first="489" last="502">
      <title>Japanese encephalitis virus core protein inhibits stress granule formation through an interaction with Caprin-1 and facilitates viral propagation.</title>
      <authorList>
        <person name="Katoh H."/>
        <person name="Okamoto T."/>
        <person name="Fukuhara T."/>
        <person name="Kambara H."/>
        <person name="Morita E."/>
        <person name="Mori Y."/>
        <person name="Kamitani W."/>
        <person name="Matsuura Y."/>
      </authorList>
      <dbReference type="PubMed" id="23097442"/>
      <dbReference type="DOI" id="10.1128/jvi.02186-12"/>
    </citation>
    <scope>INTERACTION WITH JAPANESE ENCEPHALITIS VIRUS CAPSID PROTEIN C (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="18">
    <citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
      <title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
      <authorList>
        <person name="Bian Y."/>
        <person name="Song C."/>
        <person name="Cheng K."/>
        <person name="Dong M."/>
        <person name="Wang F."/>
        <person name="Huang J."/>
        <person name="Sun D."/>
        <person name="Wang L."/>
        <person name="Ye M."/>
        <person name="Zou H."/>
      </authorList>
      <dbReference type="PubMed" id="24275569"/>
      <dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-335 AND SER-343</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Liver</tissue>
    </source>
  </reference>
  <reference key="19">
    <citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
      <title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
      <authorList>
        <person name="Guo A."/>
        <person name="Gu H."/>
        <person name="Zhou J."/>
        <person name="Mulhern D."/>
        <person name="Wang Y."/>
        <person name="Lee K.A."/>
        <person name="Yang V."/>
        <person name="Aguiar M."/>
        <person name="Kornhauser J."/>
        <person name="Jia X."/>
        <person name="Ren J."/>
        <person name="Beausoleil S.A."/>
        <person name="Silva J.C."/>
        <person name="Vemulapalli V."/>
        <person name="Bedford M.T."/>
        <person name="Comb M.J."/>
      </authorList>
      <dbReference type="PubMed" id="24129315"/>
      <dbReference type="DOI" id="10.1074/mcp.o113.027870"/>
    </citation>
    <scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-626; ARG-633; ARG-640 AND ARG-698</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Colon carcinoma</tissue>
    </source>
  </reference>
  <reference key="20">
    <citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
      <title>N-terminome analysis of the human mitochondrial proteome.</title>
      <authorList>
        <person name="Vaca Jacome A.S."/>
        <person name="Rabilloud T."/>
        <person name="Schaeffer-Reiss C."/>
        <person name="Rompais M."/>
        <person name="Ayoub D."/>
        <person name="Lane L."/>
        <person name="Bairoch A."/>
        <person name="Van Dorsselaer A."/>
        <person name="Carapito C."/>
      </authorList>
      <dbReference type="PubMed" id="25944712"/>
      <dbReference type="DOI" id="10.1002/pmic.201400617"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="21">
    <citation type="journal article" date="2016" name="J. Cell Biol." volume="212" first="845" last="860">
      <title>G3BP-Caprin1-USP10 complexes mediate stress granule condensation and associate with 40S subunits.</title>
      <authorList>
        <person name="Kedersha N."/>
        <person name="Panas M.D."/>
        <person name="Achorn C.A."/>
        <person name="Lyons S."/>
        <person name="Tisdale S."/>
        <person name="Hickman T."/>
        <person name="Thomas M."/>
        <person name="Lieberman J."/>
        <person name="McInerney G.M."/>
        <person name="Ivanov P."/>
        <person name="Anderson P."/>
      </authorList>
      <dbReference type="PubMed" id="27022092"/>
      <dbReference type="DOI" id="10.1083/jcb.201508028"/>
    </citation>
    <scope>INTERACTION WITH G3BP1 AND G3BP2</scope>
  </reference>
  <reference key="22">
    <citation type="journal article" date="2017" name="Biochem. J." volume="474" first="3109" last="3120">
      <title>The helicase, DDX3X, interacts with poly(A)-binding protein 1 (PABP1) and caprin-1 at the leading edge of migrating fibroblasts and is required for efficient cell spreading.</title>
      <authorList>
        <person name="Copsey A.C."/>
        <person name="Cooper S."/>
        <person name="Parker R."/>
        <person name="Lineham E."/>
        <person name="Lapworth C."/>
        <person name="Jallad D."/>
        <person name="Sweet S."/>
        <person name="Morley S.J."/>
      </authorList>
      <dbReference type="PubMed" id="28733330"/>
      <dbReference type="DOI" id="10.1042/bcj20170354"/>
    </citation>
    <scope>INTERACTION WITH DDX3X</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="23">
    <citation type="journal article" date="2017" name="J. Virol.">
      <title>Zika virus hijacks stress granule proteins and modulates the host stress response.</title>
      <authorList>
        <person name="Hou S."/>
        <person name="Kumar A."/>
        <person name="Xu Z."/>
        <person name="Airo A.M."/>
        <person name="Stryapunina I."/>
        <person name="Wong C.P."/>
        <person name="Branton W."/>
        <person name="Tchesnokov E."/>
        <person name="Goette M."/>
        <person name="Power C."/>
        <person name="Hobman T.C."/>
      </authorList>
      <dbReference type="PubMed" id="28592527"/>
      <dbReference type="DOI" id="10.1128/jvi.00474-17"/>
    </citation>
    <scope>INTERACTION WITH ZIKA VIRUS CAPSID PROTEIN C (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="24">
    <citation type="journal article" date="2017" name="J. Virol." volume="91">
      <title>Mammalian Orthoreovirus Factories Modulate Stress Granule Protein Localization by Interaction with G3BP1.</title>
      <authorList>
        <person name="Choudhury P."/>
        <person name="Bussiere L.D."/>
        <person name="Miller C.L."/>
      </authorList>
      <dbReference type="PubMed" id="28794026"/>
      <dbReference type="DOI" id="10.1128/jvi.01298-17"/>
    </citation>
    <scope>SUBCELLULAR LOCATION (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="25">
    <citation type="journal article" date="2018" name="J. Virol." volume="92">
      <title>Rotavirus Induces Formation of Remodeled Stress Granules and P Bodies and Their Sequestration in Viroplasms To Promote Progeny Virus Production.</title>
      <authorList>
        <person name="Dhillon P."/>
        <person name="Rao C.D."/>
      </authorList>
      <dbReference type="PubMed" id="30258011"/>
      <dbReference type="DOI" id="10.1128/jvi.01363-18"/>
    </citation>
    <scope>INTERACTION WITH ROTAVIRUS A NON-STRUCTURAL PROTEIN 5 (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="26">
    <citation type="journal article" date="2019" name="Science" volume="365" first="825" last="829">
      <title>Phospho-dependent phase separation of FMRP and CAPRIN1 recapitulates regulation of translation and deadenylation.</title>
      <authorList>
        <person name="Kim T.H."/>
        <person name="Tsang B."/>
        <person name="Vernon R.M."/>
        <person name="Sonenberg N."/>
        <person name="Kay L.E."/>
        <person name="Forman-Kay J.D."/>
      </authorList>
      <dbReference type="PubMed" id="31439799"/>
      <dbReference type="DOI" id="10.1126/science.aax4240"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>INTERACTION WITH FMR1</scope>
    <scope>PHOSPHORYLATION AT TYR-625; TYR-636; TYR-639; TYR-651; TYR-662; TYR-665 AND TYR-670</scope>
    <scope>DOMAIN</scope>
    <scope>MUTAGENESIS OF ARG-608; ARG-612; ARG-616; ARG-619; ARG-626; ARG-633; ARG-640; ARG-660; ARG-667; ARG-676; ARG-684; ARG-688; ARG-690; ARG-695 AND ARG-698</scope>
  </reference>
  <reference key="27">
    <citation type="journal article" date="2020" name="Cell" volume="181" first="306" last="324">
      <title>Competing protein-RNA interaction networks control multiphase intracellular organization.</title>
      <authorList>
        <person name="Sanders D.W."/>
        <person name="Kedersha N."/>
        <person name="Lee D.S.W."/>
        <person name="Strom A.R."/>
        <person name="Drake V."/>
        <person name="Riback J.A."/>
        <person name="Bracha D."/>
        <person name="Eeftens J.M."/>
        <person name="Iwanicki A."/>
        <person name="Wang A."/>
        <person name="Wei M.T."/>
        <person name="Whitney G."/>
        <person name="Lyons S.M."/>
        <person name="Anderson P."/>
        <person name="Jacobs W.M."/>
        <person name="Ivanov P."/>
        <person name="Brangwynne C.P."/>
      </authorList>
      <dbReference type="PubMed" id="32302570"/>
      <dbReference type="DOI" id="10.1016/j.cell.2020.03.050"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH G3BP1</scope>
  </reference>
  <reference key="28">
    <citation type="journal article" date="2020" name="Cell" volume="181" first="325" last="345">
      <title>G3BP1 is a tunable switch that triggers phase separation to assemble stress granules.</title>
      <authorList>
        <person name="Yang P."/>
        <person name="Mathieu C."/>
        <person name="Kolaitis R.M."/>
        <person name="Zhang P."/>
        <person name="Messing J."/>
        <person name="Yurtsever U."/>
        <person name="Yang Z."/>
        <person name="Wu J."/>
        <person name="Li Y."/>
        <person name="Pan Q."/>
        <person name="Yu J."/>
        <person name="Martin E.W."/>
        <person name="Mittag T."/>
        <person name="Kim H.J."/>
        <person name="Taylor J.P."/>
      </authorList>
      <dbReference type="PubMed" id="32302571"/>
      <dbReference type="DOI" id="10.1016/j.cell.2020.03.046"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH G3BP1</scope>
    <scope>MUTAGENESIS OF PHE-372</scope>
  </reference>
  <reference key="29">
    <citation type="journal article" date="2020" name="Cell" volume="181" first="346" last="361">
      <title>RNA-Induced conformational switching and clustering of G3BP drive stress granule assembly by condensation.</title>
      <authorList>
        <person name="Guillen-Boixet J."/>
        <person name="Kopach A."/>
        <person name="Holehouse A.S."/>
        <person name="Wittmann S."/>
        <person name="Jahnel M."/>
        <person name="Schluessler R."/>
        <person name="Kim K."/>
        <person name="Trussina I.R.E.A."/>
        <person name="Wang J."/>
        <person name="Mateju D."/>
        <person name="Poser I."/>
        <person name="Maharana S."/>
        <person name="Ruer-Gruss M."/>
        <person name="Richter D."/>
        <person name="Zhang X."/>
        <person name="Chang Y.T."/>
        <person name="Guck J."/>
        <person name="Honigmann A."/>
        <person name="Mahamid J."/>
        <person name="Hyman A.A."/>
        <person name="Pappu R.V."/>
        <person name="Alberti S."/>
        <person name="Franzmann T.M."/>
      </authorList>
      <dbReference type="PubMed" id="32302572"/>
      <dbReference type="DOI" id="10.1016/j.cell.2020.03.049"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH G3BP1</scope>
  </reference>
  <reference key="30">
    <citation type="journal article" date="2021" name="Proc. Natl. Acad. Sci. U.S.A." volume="118">
      <title>Interaction hot spots for phase separation revealed by NMR studies of a CAPRIN1 condensed phase.</title>
      <authorList>
        <person name="Kim T.H."/>
        <person name="Payliss B.J."/>
        <person name="Nosella M.L."/>
        <person name="Lee I.T.W."/>
        <person name="Toyama Y."/>
        <person name="Forman-Kay J.D."/>
        <person name="Kay L.E."/>
      </authorList>
      <dbReference type="PubMed" id="34074792"/>
      <dbReference type="DOI" id="10.1073/pnas.2104897118"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>ACTIVITY REGULATION</scope>
    <scope>DOMAIN</scope>
    <scope>GLYCOSYLATION AT SER-644 AND SER-649</scope>
    <scope>MUTAGENESIS OF 624-GLY--ARG-626; 638-GLY--ARG-640; 660-ARG--TYR-662; 680-GLN--GLY-682 AND 704-ASN--GLN-706</scope>
  </reference>
  <reference key="31">
    <citation type="journal article" date="2022" name="J. Biol. Chem." volume="298" first="102552" last="102552">
      <title>Tryptophan mutations in G3BP1 tune the stability of a cellular signaling hub by weakening transient interactions with Caprin1 and USP10.</title>
      <authorList>
        <person name="Sheehan C.T."/>
        <person name="Hampton T.H."/>
        <person name="Madden D.R."/>
      </authorList>
      <dbReference type="PubMed" id="36183834"/>
      <dbReference type="DOI" id="10.1016/j.jbc.2022.102552"/>
    </citation>
    <scope>INTERACTION WITH G3BP1</scope>
    <scope>MUTAGENESIS OF TYR-370; PHE-372; ILE-373; SER-376 AND MET-377</scope>
  </reference>
  <reference key="32">
    <citation type="journal article" date="2022" name="Proc. Natl. Acad. Sci. U.S.A." volume="119" first="e2210492119" last="e2210492119">
      <title>Mapping the per-residue surface electrostatic potential of CAPRIN1 along its phase-separation trajectory.</title>
      <authorList>
        <person name="Toyama Y."/>
        <person name="Rangadurai A.K."/>
        <person name="Forman-Kay J.D."/>
        <person name="Kay L.E."/>
      </authorList>
      <dbReference type="PubMed" id="36040869"/>
      <dbReference type="DOI" id="10.1073/pnas.2210492119"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>ACTIVITY REGULATION</scope>
    <scope>DOMAIN</scope>
  </reference>
  <reference key="33">
    <citation type="journal article" date="2022" name="Sci. Adv." volume="8" first="eabo7112" last="eabo7112">
      <title>De novo variants in genes regulating stress granule assembly associate with neurodevelopmental disorders.</title>
      <authorList>
        <person name="Jia X."/>
        <person name="Zhang S."/>
        <person name="Tan S."/>
        <person name="Du B."/>
        <person name="He M."/>
        <person name="Qin H."/>
        <person name="Chen J."/>
        <person name="Duan X."/>
        <person name="Luo J."/>
        <person name="Chen F."/>
        <person name="Ouyang L."/>
        <person name="Wang J."/>
        <person name="Chen G."/>
        <person name="Yu B."/>
        <person name="Zhang G."/>
        <person name="Zhang Z."/>
        <person name="Lyu Y."/>
        <person name="Huang Y."/>
        <person name="Jiao J."/>
        <person name="Chen J.Y.H."/>
        <person name="Swoboda K.J."/>
        <person name="Agolini E."/>
        <person name="Novelli A."/>
        <person name="Leoni C."/>
        <person name="Zampino G."/>
        <person name="Cappuccio G."/>
        <person name="Brunetti-Pierri N."/>
        <person name="Gerard B."/>
        <person name="Ginglinger E."/>
        <person name="Richer J."/>
        <person name="McMillan H."/>
        <person name="White-Brown A."/>
        <person name="Hoekzema K."/>
        <person name="Bernier R.A."/>
        <person name="Kurtz-Nelson E.C."/>
        <person name="Earl R.K."/>
        <person name="Meddens C."/>
        <person name="Alders M."/>
        <person name="Fuchs M."/>
        <person name="Caumes R."/>
        <person name="Brunelle P."/>
        <person name="Smol T."/>
        <person name="Kuehl R."/>
        <person name="Day-Salvatore D.L."/>
        <person name="Monaghan K.G."/>
        <person name="Morrow M.M."/>
        <person name="Eichler E.E."/>
        <person name="Hu Z."/>
        <person name="Yuan L."/>
        <person name="Tan J."/>
        <person name="Xia K."/>
        <person name="Shen Y."/>
        <person name="Guo H."/>
      </authorList>
      <dbReference type="PubMed" id="35977029"/>
      <dbReference type="DOI" id="10.1126/sciadv.abo7112"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH G3BP1 AND G3BP1</scope>
    <scope>VARIANTS LYS-373; HIS-446 AND PRO-484</scope>
    <scope>CHARACTERIZATION OF VARIANTS LYS-373; HIS-446 AND PRO-484</scope>
  </reference>
  <reference key="34">
    <citation type="journal article" date="2022" name="Proc. Natl. Acad. Sci. U.S.A." volume="119" first="e2207975119" last="e2207975119">
      <title>Yin and yang regulation of stress granules by Caprin-1.</title>
      <authorList>
        <person name="Song D."/>
        <person name="Kuang L."/>
        <person name="Yang L."/>
        <person name="Wang L."/>
        <person name="Li H."/>
        <person name="Li X."/>
        <person name="Zhu Z."/>
        <person name="Shi C."/>
        <person name="Zhu H."/>
        <person name="Gong W."/>
      </authorList>
      <dbReference type="PubMed" id="36279435"/>
      <dbReference type="DOI" id="10.1073/pnas.2207975119"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.46 ANGSTROMS) OF 369-378 IN COMPLEX WITH G3BP1</scope>
    <scope>INTERACTION WITH G3BP1</scope>
  </reference>
  <reference key="35">
    <citation type="journal article" date="2022" name="Cell. Mol. Life Sci." volume="79" first="526" last="526">
      <title>CAPRIN1P512L causes aberrant protein aggregation and associates with early-onset ataxia.</title>
      <authorList>
        <person name="Delle Vedove A."/>
        <person name="Natarajan J."/>
        <person name="Zanni G."/>
        <person name="Eckenweiler M."/>
        <person name="Muinos-Buehl A."/>
        <person name="Storbeck M."/>
        <person name="Guillen Boixet J."/>
        <person name="Barresi S."/>
        <person name="Pizzi S."/>
        <person name="Hoelker I."/>
        <person name="Koerber F."/>
        <person name="Franzmann T.M."/>
        <person name="Bertini E.S."/>
        <person name="Kirschner J."/>
        <person name="Alberti S."/>
        <person name="Tartaglia M."/>
        <person name="Wirth B."/>
      </authorList>
      <dbReference type="PubMed" id="36136249"/>
      <dbReference type="DOI" id="10.1007/s00018-022-04544-3"/>
    </citation>
    <scope>VARIANT CONDCAC LEU-512</scope>
    <scope>INVOLVEMENT IN CONDCAC</scope>
    <scope>CHARACTERIZATION OF VARIANT CONDCAC LEU-512</scope>
  </reference>
  <reference key="36">
    <citation type="journal article" date="2023" name="Brain" volume="146" first="534" last="548">
      <title>CAPRIN1 haploinsufficiency causes a neurodevelopmental disorder with language impairment, ADHD and ASD.</title>
      <authorList>
        <person name="Pavinato L."/>
        <person name="Delle Vedove A."/>
        <person name="Carli D."/>
        <person name="Ferrero M."/>
        <person name="Carestiato S."/>
        <person name="Howe J.L."/>
        <person name="Agolini E."/>
        <person name="Coviello D.A."/>
        <person name="van de Laar I."/>
        <person name="Au P.Y.B."/>
        <person name="Di Gregorio E."/>
        <person name="Fabbiani A."/>
        <person name="Croci S."/>
        <person name="Mencarelli M.A."/>
        <person name="Bruno L.P."/>
        <person name="Renieri A."/>
        <person name="Veltra D."/>
        <person name="Sofocleous C."/>
        <person name="Faivre L."/>
        <person name="Mazel B."/>
        <person name="Safraou H."/>
        <person name="Denomme-Pichon A.S."/>
        <person name="van Slegtenhorst M.A."/>
        <person name="Giesbertz N."/>
        <person name="van Jaarsveld R.H."/>
        <person name="Childers A."/>
        <person name="Rogers R.C."/>
        <person name="Novelli A."/>
        <person name="De Rubeis S."/>
        <person name="Buxbaum J.D."/>
        <person name="Scherer S.W."/>
        <person name="Ferrero G.B."/>
        <person name="Wirth B."/>
        <person name="Brusco A."/>
      </authorList>
      <dbReference type="PubMed" id="35979925"/>
      <dbReference type="DOI" id="10.1093/brain/awac278"/>
    </citation>
    <scope>VARIANTS NEDLAAD 298-GLN--ASN-709 DEL; 310-LYS--ASN-709 DEL; 358-ARG--ASN-709 DEL; 399-GLN--ASN-709 DEL; 458-ARG--ASN-709 DEL AND 582-GLN--ASN-709 DEL</scope>
    <scope>INVOLVEMENT IN NEDLAAD</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>FUNCTION</scope>
  </reference>
  <comment type="function">
    <text evidence="5 14 15 16 18 19 20 21 24">mRNA-binding protein that acts as a regulator of mRNAs transport, translation and/or stability, and which is involved in neurogenesis, synaptic plasticity in neurons and cell proliferation and migration in multiple cell types (PubMed:17210633, PubMed:31439799, PubMed:35979925). Plays an essential role in cytoplasmic stress granule formation (PubMed:35977029). Acts as an mRNA regulator by mediating formation of some phase-separated membraneless compartment: undergoes liquid-liquid phase separation upon binding to target mRNAs, leading to assemble mRNAs into cytoplasmic ribonucleoprotein granules that concentrate mRNAs with associated regulatory factors (PubMed:31439799, PubMed:32302570, PubMed:32302571, PubMed:32302572, PubMed:34074792, PubMed:36040869, PubMed:36279435). Undergoes liquid-liquid phase separation following phosphorylation and interaction with FMR1, promoting formation of cytoplasmic ribonucleoprotein granules that concentrate mRNAs with factors that inhibit translation and mediate deadenylation of target mRNAs (PubMed:31439799). In these cytoplasmic ribonucleoprotein granules, CAPRIN1 mediates recruitment of CNOT7 deadenylase, leading to mRNA deadenylation and degradation (PubMed:31439799). Binds directly and selectively to MYC and CCND2 mRNAs (PubMed:17210633). In neuronal cells, directly binds to several mRNAs associated with RNA granules, including BDNF, CAMK2A, CREB1, MAP2, NTRK2 mRNAs, as well as to GRIN1 and KPNB1 mRNAs, but not to rRNAs (PubMed:17210633).</text>
  </comment>
  <comment type="activity regulation">
    <text evidence="18 21">Ability to mediate liquid-liquid phase separation is regulated by ATP: moderate concentrations of ATP enhance phase separation, whereas high concentrations of ATP lead to inhibition of phase separation.</text>
  </comment>
  <comment type="subunit">
    <text evidence="4 5 6 9 11 14 15 16 17 19 23">May form homomultimers (PubMed:14764709). Interacts with G3BP1; interaction is direct and promotes stress granule formation (PubMed:17210633, PubMed:27022092, PubMed:32302570, PubMed:32302571, PubMed:32302572, PubMed:35977029, PubMed:36183834, PubMed:36279435). Interacts with G3BP2; interaction is direct and promotes stress granule formation (PubMed:27022092, PubMed:35977029). Interacts with PQBP1 (PubMed:21933836). Interacts with DDX3X (PubMed:28733330). Interacts (when phosphorylated by EPHA4) with FMR1; interaction with FMR1 promotes formation of a membraneless compartment (PubMed:31439799).</text>
  </comment>
  <comment type="subunit">
    <text evidence="10">(Microbial infection) Interacts with Zika virus capsid protein C; this interaction is probably linked to the inhibition of stress granules formation by the virus.</text>
  </comment>
  <comment type="subunit">
    <text evidence="13">(Microbial infection) Interacts with rotavirus A non-structural protein 5; this interaction probably plays a role in the sequestration of CAPRIN1 in viral factories.</text>
  </comment>
  <comment type="subunit">
    <text evidence="8">(Microbial infection) Interacts with Japanese encephalitis virus capsid protein C; this interaction is involved in the suppression of the integrated stress response by the virus.</text>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1047080">
      <id>Q14444</id>
    </interactant>
    <interactant intactId="EBI-1047359">
      <id>Q13283</id>
      <label>G3BP1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>8</experiments>
  </comment>
  <comment type="subcellular location">
    <subcellularLocation>
      <location evidence="5 14">Cytoplasm</location>
      <location evidence="5 14">Cytoplasmic ribonucleoprotein granule</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="11">Cytoplasm</location>
      <location evidence="11">Cytosol</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="20">Cell projection</location>
      <location evidence="20">Dendrite</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="11">Cell projection</location>
      <location evidence="11">Lamellipodium</location>
    </subcellularLocation>
    <text evidence="11 14">Mediates formation and localizes to cytoplasmic ribonucleoprotein membraneless compartments (PubMed:31439799). Associated with RNA granules. At the leading edge of migrating fibroblasts, colocalizes with DDX3X (PubMed:28733330).</text>
  </comment>
  <comment type="subcellular location">
    <subcellularLocation>
      <location>Cytoplasm</location>
      <location>Cytosol</location>
    </subcellularLocation>
    <text evidence="12">(Microbial infection) In case of reovirus infection, associates with the outer peripheries of viral factories in a G3BP1 dependent manner.</text>
  </comment>
  <comment type="alternative products">
    <event type="alternative splicing"/>
    <isoform>
      <id>Q14444-1</id>
      <name>1</name>
      <sequence type="displayed"/>
    </isoform>
    <isoform>
      <id>Q14444-2</id>
      <name>2</name>
      <sequence type="described" ref="VSP_032687"/>
    </isoform>
  </comment>
  <comment type="tissue specificity">
    <text evidence="25">Ubiquitous.</text>
  </comment>
  <comment type="domain">
    <text evidence="14 18 21">The C-terminal disordered region undergoes liquid-liquid phase separation (LLPS) for the formation of a membraneless compartment that concentrates mRNAs with associated regulatory factors (PubMed:31439799, PubMed:34074792, PubMed:36040869). CAPRIN1 molecules in the condensed phase are neutral (PubMed:36040869). mRNA-binding promotes phase separation (PubMed:31439799). Moderate concentrations of ATP enhance phase separation by reducing the electrostatic potential of CAPRIN1, thereby promoting intermolecular interactions (PubMed:34074792, PubMed:36040869). In contrast, high concentrations of ATP invert the electrostatic potential of CAPRIN1, so that CAPRIN1 molecules become negatively charged, lead to inhibition of phase separation (PubMed:36040869).</text>
  </comment>
  <comment type="PTM">
    <text evidence="14">Tyrosine phosphorylation by EPHA4 promotes interaction with FMR1 and liquid-liquid phase separation (LLPS) for the formation of a membraneless compartment that concentrates mRNAs with associated regulatory factors.</text>
  </comment>
  <comment type="PTM">
    <text evidence="7 18">O-glycosylated (O-GlcNAcylated), in a cell cycle-dependent manner (PubMed:22967762). O-glycosylation by OGT inhibit ability to undergo liquid-liquid phase separation (LLPS) (PubMed:34074792).</text>
  </comment>
  <comment type="disease" evidence="22">
    <disease id="DI-06807">
      <name>Neurodegeneration, childhood-onset, with cerebellar ataxia and cognitive decline</name>
      <acronym>CONDCAC</acronym>
      <description>A neurodegenerative disorder characterized by early-onset ataxia, dysarthria, cognitive decline, sensorimotor axonal neuropathy and muscle weakness. Brain imaging shows cerebellar atrophy.</description>
      <dbReference type="MIM" id="620636"/>
    </disease>
    <text>The disease is caused by variants affecting the gene represented in this entry.</text>
  </comment>
  <comment type="disease" evidence="20">
    <disease id="DI-06881">
      <name>Neurodevelopmental disorder with language impairment, autism, and attention deficit-hyperactivity disorder</name>
      <acronym>NEDLAAD</acronym>
      <description>An autosomal dominant disorder with variable expressivity and incomplete penetrance. It is characterized by language impairment, speech delay, intellectual disability, attention deficit hyperactivity disorder and autism spectrum disorder. Additional variable features include developmental delay, seizures, skeletal anomalies, respiratory difficulties, and ophthalmologic anomalies.</description>
      <dbReference type="MIM" id="620782"/>
    </disease>
    <text>The disease is caused by variants affecting the gene represented in this entry.</text>
  </comment>
  <comment type="similarity">
    <text evidence="29">Belongs to the caprin family.</text>
  </comment>
  <comment type="caution">
    <text evidence="30">Was originally thought to be a GPI-anchored membrane protein.</text>
  </comment>
  <comment type="sequence caution" evidence="29">
    <conflict type="erroneous gene model prediction">
      <sequence resource="EMBL-CDS" id="CAA61751" version="1"/>
    </conflict>
  </comment>
  <comment type="sequence caution" evidence="29">
    <conflict type="frameshift">
      <sequence resource="EMBL-CDS" id="CAA88096" version="1"/>
    </conflict>
  </comment>
  <dbReference type="EMBL" id="Z48042">
    <property type="protein sequence ID" value="CAA88096.1"/>
    <property type="status" value="ALT_FRAME"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AC090469">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="CH471064">
    <property type="protein sequence ID" value="EAW68177.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="CH471064">
    <property type="protein sequence ID" value="EAW68178.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="CH471064">
    <property type="protein sequence ID" value="EAW68179.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC001731">
    <property type="protein sequence ID" value="AAH01731.2"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="X89572">
    <property type="protein sequence ID" value="CAA61751.1"/>
    <property type="status" value="ALT_SEQ"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BK001101">
    <property type="protein sequence ID" value="DAA01118.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BK001104">
    <property type="protein sequence ID" value="DAA01121.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BR000867">
    <property type="protein sequence ID" value="FAA00692.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS31453.1">
    <molecule id="Q14444-1"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS31454.1">
    <molecule id="Q14444-2"/>
  </dbReference>
  <dbReference type="PIR" id="A57352">
    <property type="entry name" value="A57352"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_005889.3">
    <molecule id="Q14444-1"/>
    <property type="nucleotide sequence ID" value="NM_005898.4"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_976240.1">
    <molecule id="Q14444-2"/>
    <property type="nucleotide sequence ID" value="NM_203364.2"/>
  </dbReference>
  <dbReference type="RefSeq" id="XP_016873238.1">
    <property type="nucleotide sequence ID" value="XM_017017749.1"/>
  </dbReference>
  <dbReference type="PDB" id="4WBE">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.05 A"/>
    <property type="chains" value="A/B/C=132-251"/>
  </dbReference>
  <dbReference type="PDB" id="4WBP">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.50 A"/>
    <property type="chains" value="A/B=132-251"/>
  </dbReference>
  <dbReference type="PDB" id="6TA7">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.93 A"/>
    <property type="chains" value="G/H=356-386"/>
  </dbReference>
  <dbReference type="PDB" id="7XHG">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.46 A"/>
    <property type="chains" value="E/F/G=369-378"/>
  </dbReference>
  <dbReference type="PDB" id="8TH7">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.88 A"/>
    <property type="chains" value="C/D=360-381"/>
  </dbReference>
  <dbReference type="PDBsum" id="4WBE"/>
  <dbReference type="PDBsum" id="4WBP"/>
  <dbReference type="PDBsum" id="6TA7"/>
  <dbReference type="PDBsum" id="7XHG"/>
  <dbReference type="PDBsum" id="8TH7"/>
  <dbReference type="AlphaFoldDB" id="Q14444"/>
  <dbReference type="SMR" id="Q14444"/>
  <dbReference type="BioGRID" id="110252">
    <property type="interactions" value="448"/>
  </dbReference>
  <dbReference type="CORUM" id="Q14444"/>
  <dbReference type="IntAct" id="Q14444">
    <property type="interactions" value="226"/>
  </dbReference>
  <dbReference type="MINT" id="Q14444"/>
  <dbReference type="STRING" id="9606.ENSP00000340329"/>
  <dbReference type="ChEMBL" id="CHEMBL4295821"/>
  <dbReference type="GlyCosmos" id="Q14444">
    <property type="glycosylation" value="5 sites, 1 glycan"/>
  </dbReference>
  <dbReference type="GlyGen" id="Q14444">
    <property type="glycosylation" value="16 sites, 1 O-linked glycan (14 sites)"/>
  </dbReference>
  <dbReference type="iPTMnet" id="Q14444"/>
  <dbReference type="MetOSite" id="Q14444"/>
  <dbReference type="PhosphoSitePlus" id="Q14444"/>
  <dbReference type="SwissPalm" id="Q14444"/>
  <dbReference type="BioMuta" id="CAPRIN1"/>
  <dbReference type="DMDM" id="182676426"/>
  <dbReference type="CPTAC" id="CPTAC-37"/>
  <dbReference type="CPTAC" id="CPTAC-38"/>
  <dbReference type="jPOST" id="Q14444"/>
  <dbReference type="MassIVE" id="Q14444"/>
  <dbReference type="PaxDb" id="9606-ENSP00000340329"/>
  <dbReference type="PeptideAtlas" id="Q14444"/>
  <dbReference type="ProteomicsDB" id="59992">
    <molecule id="Q14444-1"/>
  </dbReference>
  <dbReference type="ProteomicsDB" id="59993">
    <molecule id="Q14444-2"/>
  </dbReference>
  <dbReference type="Pumba" id="Q14444"/>
  <dbReference type="Antibodypedia" id="12960">
    <property type="antibodies" value="371 antibodies from 33 providers"/>
  </dbReference>
  <dbReference type="DNASU" id="4076"/>
  <dbReference type="Ensembl" id="ENST00000341394.9">
    <molecule id="Q14444-1"/>
    <property type="protein sequence ID" value="ENSP00000340329.4"/>
    <property type="gene ID" value="ENSG00000135387.21"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000389645.7">
    <molecule id="Q14444-2"/>
    <property type="protein sequence ID" value="ENSP00000374296.3"/>
    <property type="gene ID" value="ENSG00000135387.21"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000530820.5">
    <molecule id="Q14444-2"/>
    <property type="protein sequence ID" value="ENSP00000434204.1"/>
    <property type="gene ID" value="ENSG00000135387.21"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000532820.5">
    <molecule id="Q14444-1"/>
    <property type="protein sequence ID" value="ENSP00000434150.1"/>
    <property type="gene ID" value="ENSG00000135387.21"/>
  </dbReference>
  <dbReference type="GeneID" id="4076"/>
  <dbReference type="KEGG" id="hsa:4076"/>
  <dbReference type="MANE-Select" id="ENST00000341394.9">
    <property type="protein sequence ID" value="ENSP00000340329.4"/>
    <property type="RefSeq nucleotide sequence ID" value="NM_005898.5"/>
    <property type="RefSeq protein sequence ID" value="NP_005889.3"/>
  </dbReference>
  <dbReference type="UCSC" id="uc001mvg.4">
    <molecule id="Q14444-1"/>
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="AGR" id="HGNC:6743"/>
  <dbReference type="CTD" id="4076"/>
  <dbReference type="DisGeNET" id="4076"/>
  <dbReference type="GeneCards" id="CAPRIN1"/>
  <dbReference type="HGNC" id="HGNC:6743">
    <property type="gene designation" value="CAPRIN1"/>
  </dbReference>
  <dbReference type="HPA" id="ENSG00000135387">
    <property type="expression patterns" value="Low tissue specificity"/>
  </dbReference>
  <dbReference type="MalaCards" id="CAPRIN1"/>
  <dbReference type="MIM" id="601178">
    <property type="type" value="gene"/>
  </dbReference>
  <dbReference type="MIM" id="620636">
    <property type="type" value="phenotype"/>
  </dbReference>
  <dbReference type="MIM" id="620782">
    <property type="type" value="phenotype"/>
  </dbReference>
  <dbReference type="neXtProt" id="NX_Q14444"/>
  <dbReference type="OpenTargets" id="ENSG00000135387"/>
  <dbReference type="Orphanet" id="528084">
    <property type="disease" value="Non-specific syndromic intellectual disability"/>
  </dbReference>
  <dbReference type="PharmGKB" id="PA30508"/>
  <dbReference type="VEuPathDB" id="HostDB:ENSG00000135387"/>
  <dbReference type="eggNOG" id="ENOG502QUGC">
    <property type="taxonomic scope" value="Eukaryota"/>
  </dbReference>
  <dbReference type="GeneTree" id="ENSGT00940000153438"/>
  <dbReference type="InParanoid" id="Q14444"/>
  <dbReference type="OMA" id="GNNHWNS"/>
  <dbReference type="OrthoDB" id="5403347at2759"/>
  <dbReference type="PhylomeDB" id="Q14444"/>
  <dbReference type="TreeFam" id="TF329471"/>
  <dbReference type="PathwayCommons" id="Q14444"/>
  <dbReference type="SignaLink" id="Q14444"/>
  <dbReference type="SIGNOR" id="Q14444"/>
  <dbReference type="BioGRID-ORCS" id="4076">
    <property type="hits" value="71 hits in 1159 CRISPR screens"/>
  </dbReference>
  <dbReference type="ChiTaRS" id="CAPRIN1">
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="EvolutionaryTrace" id="Q14444"/>
  <dbReference type="GeneWiki" id="CAPRIN1"/>
  <dbReference type="GenomeRNAi" id="4076"/>
  <dbReference type="Pharos" id="Q14444">
    <property type="development level" value="Tbio"/>
  </dbReference>
  <dbReference type="PRO" id="PR:Q14444"/>
  <dbReference type="Proteomes" id="UP000005640">
    <property type="component" value="Chromosome 11"/>
  </dbReference>
  <dbReference type="RNAct" id="Q14444">
    <property type="molecule type" value="protein"/>
  </dbReference>
  <dbReference type="Bgee" id="ENSG00000135387">
    <property type="expression patterns" value="Expressed in cortical plate and 213 other cell types or tissues"/>
  </dbReference>
  <dbReference type="ExpressionAtlas" id="Q14444">
    <property type="expression patterns" value="baseline and differential"/>
  </dbReference>
  <dbReference type="GO" id="GO:0031252">
    <property type="term" value="C:cell leading edge"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005737">
    <property type="term" value="C:cytoplasm"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0010494">
    <property type="term" value="C:cytoplasmic stress granule"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005829">
    <property type="term" value="C:cytosol"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HPA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0030425">
    <property type="term" value="C:dendrite"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-SubCell"/>
  </dbReference>
  <dbReference type="GO" id="GO:0043232">
    <property type="term" value="C:intracellular non-membrane-bounded organelle"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0030027">
    <property type="term" value="C:lamellipodium"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-SubCell"/>
  </dbReference>
  <dbReference type="GO" id="GO:0016020">
    <property type="term" value="C:membrane"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0000932">
    <property type="term" value="C:P-body"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045202">
    <property type="term" value="C:synapse"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005524">
    <property type="term" value="F:ATP binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0140693">
    <property type="term" value="F:molecular condensate scaffold activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0140677">
    <property type="term" value="F:molecular function activator activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProt"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003729">
    <property type="term" value="F:mRNA binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProt"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003723">
    <property type="term" value="F:RNA binding"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0035591">
    <property type="term" value="F:signaling adaptor activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProt"/>
  </dbReference>
  <dbReference type="GO" id="GO:0048699">
    <property type="term" value="P:generation of neurons"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0008298">
    <property type="term" value="P:intracellular mRNA localization"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0017148">
    <property type="term" value="P:negative regulation of translation"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProt"/>
  </dbReference>
  <dbReference type="GO" id="GO:0140694">
    <property type="term" value="P:non-membrane-bounded organelle assembly"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProt"/>
  </dbReference>
  <dbReference type="GO" id="GO:0050775">
    <property type="term" value="P:positive regulation of dendrite morphogenesis"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0061003">
    <property type="term" value="P:positive regulation of dendritic spine morphogenesis"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0062029">
    <property type="term" value="P:positive regulation of stress granule assembly"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0106288">
    <property type="term" value="P:regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0007416">
    <property type="term" value="P:synapse assembly"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="DisProt" id="DP02916"/>
  <dbReference type="IDEAL" id="IID00668"/>
  <dbReference type="InterPro" id="IPR028816">
    <property type="entry name" value="Caprin"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR022070">
    <property type="entry name" value="Caprin-1_C"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR041637">
    <property type="entry name" value="Caprin-1_dimer"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR22922:SF3">
    <property type="entry name" value="CAPRIN-1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR22922">
    <property type="entry name" value="GPI-ANCHORED PROTEIN P137"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF12287">
    <property type="entry name" value="Caprin-1_C"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF18293">
    <property type="entry name" value="Caprin-1_dimer"/>
    <property type="match status" value="1"/>
  </dbReference>
  <proteinExistence type="evidence at protein level"/>
  <keyword id="KW-0002">3D-structure</keyword>
  <keyword id="KW-0007">Acetylation</keyword>
  <keyword id="KW-0025">Alternative splicing</keyword>
  <keyword id="KW-0067">ATP-binding</keyword>
  <keyword id="KW-1269">Autism</keyword>
  <keyword id="KW-1268">Autism spectrum disorder</keyword>
  <keyword id="KW-0966">Cell projection</keyword>
  <keyword id="KW-0175">Coiled coil</keyword>
  <keyword id="KW-0963">Cytoplasm</keyword>
  <keyword id="KW-0221">Differentiation</keyword>
  <keyword id="KW-0903">Direct protein sequencing</keyword>
  <keyword id="KW-0225">Disease variant</keyword>
  <keyword id="KW-0325">Glycoprotein</keyword>
  <keyword id="KW-0991">Intellectual disability</keyword>
  <keyword id="KW-0488">Methylation</keyword>
  <keyword id="KW-0523">Neurodegeneration</keyword>
  <keyword id="KW-0547">Nucleotide-binding</keyword>
  <keyword id="KW-0597">Phosphoprotein</keyword>
  <keyword id="KW-0652">Protein synthesis inhibitor</keyword>
  <keyword id="KW-1267">Proteomics identification</keyword>
  <keyword id="KW-1185">Reference proteome</keyword>
  <keyword id="KW-0694">RNA-binding</keyword>
  <feature type="initiator methionine" description="Removed" evidence="33">
    <location>
      <position position="1"/>
    </location>
  </feature>
  <feature type="chain" id="PRO_0000087549" description="Caprin-1">
    <location>
      <begin position="2"/>
      <end position="709"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="3">
    <location>
      <begin position="1"/>
      <end position="50"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="3">
    <location>
      <begin position="260"/>
      <end position="291"/>
    </location>
  </feature>
  <feature type="region of interest" description="G3BP1-binding" evidence="5 24">
    <location>
      <begin position="360"/>
      <end position="381"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="3">
    <location>
      <begin position="417"/>
      <end position="446"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="3">
    <location>
      <begin position="475"/>
      <end position="499"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="14">
    <location>
      <begin position="524"/>
      <end position="709"/>
    </location>
  </feature>
  <feature type="coiled-coil region" evidence="2">
    <location>
      <begin position="60"/>
      <end position="94"/>
    </location>
  </feature>
  <feature type="coiled-coil region" evidence="2">
    <location>
      <begin position="125"/>
      <end position="153"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Polar residues" evidence="3">
    <location>
      <begin position="1"/>
      <end position="22"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Acidic residues" evidence="3">
    <location>
      <begin position="274"/>
      <end position="288"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Polar residues" evidence="3">
    <location>
      <begin position="532"/>
      <end position="609"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Polar residues" evidence="3">
    <location>
      <begin position="641"/>
      <end position="679"/>
    </location>
  </feature>
  <feature type="modified residue" description="N-acetylproline" evidence="33">
    <location>
      <position position="2"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="32">
    <location>
      <position position="10"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="34">
    <location>
      <position position="115"/>
    </location>
  </feature>
  <feature type="modified residue" description="Omega-N-methylarginine" evidence="1">
    <location>
      <position position="165"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="36">
    <location>
      <position position="335"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="36">
    <location>
      <position position="343"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphotyrosine; by EPHA4" evidence="14">
    <location>
      <position position="625"/>
    </location>
  </feature>
  <feature type="modified residue" description="Omega-N-methylarginine" evidence="35">
    <location>
      <position position="626"/>
    </location>
  </feature>
  <feature type="modified residue" description="Omega-N-methylarginine" evidence="35">
    <location>
      <position position="633"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphotyrosine; by EPHA4" evidence="14">
    <location>
      <position position="636"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphotyrosine; by EPHA4" evidence="14">
    <location>
      <position position="639"/>
    </location>
  </feature>
  <feature type="modified residue" description="Omega-N-methylarginine" evidence="35">
    <location>
      <position position="640"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphotyrosine; by EPHA4" evidence="14">
    <location>
      <position position="651"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphotyrosine; by EPHA4" evidence="14">
    <location>
      <position position="662"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphotyrosine; by EPHA4" evidence="14">
    <location>
      <position position="665"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphotyrosine; by EPHA4" evidence="14">
    <location>
      <position position="670"/>
    </location>
  </feature>
  <feature type="modified residue" description="Asymmetric dimethylarginine; alternate" evidence="35">
    <location>
      <position position="698"/>
    </location>
  </feature>
  <feature type="modified residue" description="Omega-N-methylarginine; alternate" evidence="35">
    <location>
      <position position="698"/>
    </location>
  </feature>
  <feature type="glycosylation site" description="O-linked (GlcNAc) serine" evidence="18">
    <location>
      <position position="644"/>
    </location>
  </feature>
  <feature type="glycosylation site" description="O-linked (GlcNAc) serine" evidence="18">
    <location>
      <position position="649"/>
    </location>
  </feature>
  <feature type="splice variant" id="VSP_032687" description="In isoform 2." evidence="29">
    <original>RGGPPRPNRGMPQMNTQQVN</original>
    <variation>NILWW</variation>
    <location>
      <begin position="690"/>
      <end position="709"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_042425" description="In dbSNP:rs1132973." evidence="25">
    <original>A</original>
    <variation>D</variation>
    <location>
      <position position="263"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_089530" description="In NEDLAAD; likely pathogenic." evidence="20">
    <location>
      <begin position="298"/>
      <end position="709"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_089531" description="In NEDLAAD; likely pathogenic." evidence="20">
    <location>
      <begin position="310"/>
      <end position="709"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_089532" description="In NEDLAAD; likely pathogenic." evidence="20">
    <location>
      <begin position="358"/>
      <end position="709"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_088961" description="Found in a patient with a neurodevelopmental disorder; uncertain significance; decreased function in stress granule formation shown by rescue assays in transfected CAPRIN1-deficient cells; impaired interaction with G3BP1 and G3BP2." evidence="19">
    <original>I</original>
    <variation>K</variation>
    <location>
      <position position="373"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_089533" description="In NEDLAAD; likely pathogenic; 50% decrease of transcript and protein levels in patient-derived cells compared to controls." evidence="20">
    <location>
      <begin position="399"/>
      <end position="709"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_088962" description="Found in a patient with a neurodevelopmental disorder; uncertain significance; no effect on function in stress granule formation shown by rescue assays in transfected CAPRIN1-deficient cells; no effect on interaction with G3BP1 and G3BP2." evidence="19">
    <original>Q</original>
    <variation>H</variation>
    <location>
      <position position="446"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_089534" description="In NEDLAAD; likely pathogenic." evidence="20">
    <location>
      <begin position="458"/>
      <end position="709"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_088963" description="Found in a patient with a neurodevelopmental disorder; uncertain significance; no effect on function in stress granule formation shown by rescue assays in transfected CAPRIN1-deficient cells; no effect on interaction with G3BP1 and G3BP2." evidence="19">
    <original>L</original>
    <variation>P</variation>
    <location>
      <position position="484"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_089188" description="In CONDCAC; likely pathogenic; results in altered dynamics of stress granule formation and resolution; increased protein stability measured by nano-differential scanning fluorimetry; increased protein aggregation; no effect on oligomerization." evidence="22">
    <original>P</original>
    <variation>L</variation>
    <location>
      <position position="512"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_089535" description="In NEDLAAD; likely pathogenic; 50% decrease of transcript and protein levels in patient-derived cells compared to controls." evidence="20">
    <location>
      <begin position="582"/>
      <end position="709"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_042426" description="In dbSNP:rs12282627.">
    <original>Q</original>
    <variation>H</variation>
    <location>
      <position position="588"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_042427" description="In dbSNP:rs11552285.">
    <original>R</original>
    <variation>H</variation>
    <location>
      <position position="616"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished interaction with G3BP1." evidence="23">
    <original>Y</original>
    <variation>A</variation>
    <variation>G</variation>
    <variation>P</variation>
    <variation>V</variation>
    <variation>W</variation>
    <variation>D</variation>
    <variation>E</variation>
    <variation>R</variation>
    <variation>H</variation>
    <variation>K</variation>
    <variation>S</variation>
    <variation>C</variation>
    <variation>T</variation>
    <variation>M</variation>
    <variation>N</variation>
    <variation>Q</variation>
    <location>
      <position position="370"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished interaction with G3BP1 and ability to promote stress granule formation." evidence="16 23">
    <original>F</original>
    <variation>A</variation>
    <variation>G</variation>
    <variation>I</variation>
    <variation>L</variation>
    <variation>P</variation>
    <variation>V</variation>
    <variation>W</variation>
    <variation>Y</variation>
    <variation>D</variation>
    <variation>E</variation>
    <variation>R</variation>
    <variation>H</variation>
    <variation>K</variation>
    <variation>S</variation>
    <variation>C</variation>
    <variation>T</variation>
    <variation>M</variation>
    <variation>N</variation>
    <variation>Q</variation>
    <location>
      <position position="372"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished interaction with G3BP1." evidence="23">
    <original>I</original>
    <variation>A</variation>
    <variation>G</variation>
    <variation>P</variation>
    <variation>V</variation>
    <variation>D</variation>
    <variation>E</variation>
    <variation>R</variation>
    <variation>H</variation>
    <variation>K</variation>
    <variation>S</variation>
    <variation>C</variation>
    <variation>T</variation>
    <variation>M</variation>
    <variation>N</variation>
    <variation>Q</variation>
    <location>
      <position position="373"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Increased interaction with G3BP1." evidence="23">
    <original>I</original>
    <variation>F</variation>
    <location>
      <position position="373"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished interaction with G3BP1." evidence="23">
    <original>S</original>
    <variation>A</variation>
    <variation>G</variation>
    <variation>I</variation>
    <variation>L</variation>
    <variation>P</variation>
    <variation>V</variation>
    <variation>F</variation>
    <variation>E</variation>
    <variation>R</variation>
    <variation>H</variation>
    <variation>T</variation>
    <variation>M</variation>
    <variation>Q</variation>
    <location>
      <position position="376"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Increased interaction with G3BP1." evidence="23">
    <original>S</original>
    <variation>C</variation>
    <location>
      <position position="376"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Increased interaction with G3BP1." evidence="23">
    <original>M</original>
    <variation>F</variation>
    <variation>Y</variation>
    <location>
      <position position="377"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished interaction with G3BP1." evidence="23">
    <original>M</original>
    <variation>G</variation>
    <variation>P</variation>
    <variation>K</variation>
    <location>
      <position position="377"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished ability to undergo liquid-liquid phase separation for the formation of a membraneless compartment; when associated with K-612, K-616, K-619, K-626, K-633, K-640, K-660, K-667, K-676, K-684, K-688, K-690, K-695 and K-698." evidence="14">
    <original>R</original>
    <variation>K</variation>
    <location>
      <position position="608"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Major reduction in MYC and CCND2 RNA-binding; when associated with A-633 and A-690." evidence="5">
    <original>R</original>
    <variation>A</variation>
    <location>
      <position position="612"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished ability to undergo liquid-liquid phase separation for the formation of a membraneless compartment; when associated with K-608, K-616, K-619, K-626, K-633, K-640, K-660, K-667, K-676, K-684, K-688, K-690, K-695 and K-698." evidence="14">
    <original>R</original>
    <variation>K</variation>
    <location>
      <position position="612"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished ability to undergo liquid-liquid phase separation for the formation of a membraneless compartment; when associated with K-608, K-612, K-619, K-626, K-633, K-640, K-660, K-667, K-676, K-684, K-688, K-690, K-695 and K-698." evidence="14">
    <original>R</original>
    <variation>K</variation>
    <location>
      <position position="616"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished ability to undergo liquid-liquid phase separation for the formation of a membraneless compartment; when associated with K-608, K-612, K-616, K-626, K-633, K-640, K-660, K-667, K-676, K-684, K-688, K-690, K-695 and K-698." evidence="14">
    <original>R</original>
    <variation>K</variation>
    <location>
      <position position="619"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Decreased ability to undergo liquid-liquid phase separation." evidence="18">
    <original>GYR</original>
    <variation>ASA</variation>
    <location>
      <begin position="624"/>
      <end position="626"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished ability to undergo liquid-liquid phase separation for the formation of a membraneless compartment; when associated with K-608, K-612, K-616, K-619, K-633, K-640, K-660, K-667, K-676, K-684, K-688, K-690, K-695 and K-698." evidence="14">
    <original>R</original>
    <variation>K</variation>
    <location>
      <position position="626"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Major reduction in MYC and CCND2 RNA-binding; when associated with A-612 and A-690." evidence="5">
    <original>R</original>
    <variation>A</variation>
    <location>
      <position position="633"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished ability to undergo liquid-liquid phase separation for the formation of a membraneless compartment; when associated with K-608, K-612, K-616, K-619, K-626, K-640, K-660, K-667, K-676, K-684, K-688, K-690, K-695 and K-698." evidence="14">
    <original>R</original>
    <variation>K</variation>
    <location>
      <position position="633"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Decreased ability to undergo liquid-liquid phase separation." evidence="18">
    <original>GYR</original>
    <variation>ASA</variation>
    <location>
      <begin position="638"/>
      <end position="640"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished ability to undergo liquid-liquid phase separation for the formation of a membraneless compartment; when associated with K-608, K-612, K-616, K-619, K-626, K-633, K-660, K-667, K-676, K-684, K-688, K-690, K-695 and K-698." evidence="14">
    <original>R</original>
    <variation>K</variation>
    <location>
      <position position="640"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Decreased ability to undergo liquid-liquid phase separation." evidence="18">
    <original>RDY</original>
    <variation>ASA</variation>
    <location>
      <begin position="660"/>
      <end position="662"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished ability to undergo liquid-liquid phase separation for the formation of a membraneless compartment; when associated with K-608, K-612, K-616, K-619, K-626, K-633, K-640, K-667, K-676, K-684, K-688, K-690, K-695 and K-698." evidence="14">
    <original>R</original>
    <variation>K</variation>
    <location>
      <position position="660"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished ability to undergo liquid-liquid phase separation for the formation of a membraneless compartment; when associated with K-608, K-612, K-616, K-619, K-626, K-633, K-640, K-660, K-676, K-684, K-688, K-690, K-695 and K-698." evidence="14">
    <original>R</original>
    <variation>K</variation>
    <location>
      <position position="667"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished ability to undergo liquid-liquid phase separation for the formation of a membraneless compartment; when associated with K-608, K-612, K-616, K-619, K-626, K-633, K-640, K-660, K-667, K-684, K-688, K-690, K-695 and K-698." evidence="14">
    <original>R</original>
    <variation>K</variation>
    <location>
      <position position="676"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect ability to undergo liquid-liquid phase separation." evidence="18">
    <original>QSG</original>
    <variation>ASA</variation>
    <location>
      <begin position="680"/>
      <end position="682"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished ability to undergo liquid-liquid phase separation for the formation of a membraneless compartment; when associated with K-608, K-612, K-616, K-619, K-626, K-633, K-640, K-660, K-667, K-676, K-688, K-690, K-695 and K-698." evidence="14">
    <original>R</original>
    <variation>K</variation>
    <location>
      <position position="684"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished ability to undergo liquid-liquid phase separation for the formation of a membraneless compartment; when associated with K-608, K-612, K-616, K-619, K-626, K-633, K-640, K-660, K-667, K-676, K-684, K-690, K-695 and K-698." evidence="14">
    <original>R</original>
    <variation>K</variation>
    <location>
      <position position="688"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Major reduction in MYC and CCND2 RNA-binding; when associated with A-612 and A-633." evidence="5">
    <original>R</original>
    <variation>A</variation>
    <location>
      <position position="690"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished ability to undergo liquid-liquid phase separation for the formation of a membraneless compartment; when associated with K-608, K-612, K-616, K-619, K-626, K-633, K-640, K-660, K-667, K-676, K-684, K-688, K-695 and K-698." evidence="14">
    <original>R</original>
    <variation>K</variation>
    <location>
      <position position="690"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished ability to undergo liquid-liquid phase separation for the formation of a membraneless compartment; when associated with K-608, K-612, K-616, K-619, K-626, K-633, K-640, K-660, K-667, K-676, K-684, K-688, K-690 and K-698." evidence="14">
    <original>R</original>
    <variation>K</variation>
    <location>
      <position position="695"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished ability to undergo liquid-liquid phase separation for the formation of a membraneless compartment; when associated with K-608, K-612, K-616, K-619, K-626, K-633, K-640, K-660, K-667, K-676, K-684, K-688, K-690 and K-695." evidence="14">
    <original>R</original>
    <variation>K</variation>
    <location>
      <position position="698"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect ability to undergo liquid-liquid phase separation." evidence="18">
    <original>NTQ</original>
    <variation>ASA</variation>
    <location>
      <begin position="704"/>
      <end position="706"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 1; CAA88096." evidence="29" ref="1">
    <original>Y</original>
    <variation>D</variation>
    <location>
      <position position="370"/>
    </location>
  </feature>
  <feature type="helix" evidence="37">
    <location>
      <begin position="133"/>
      <end position="158"/>
    </location>
  </feature>
  <feature type="helix" evidence="37">
    <location>
      <begin position="162"/>
      <end position="170"/>
    </location>
  </feature>
  <feature type="strand" evidence="37">
    <location>
      <begin position="172"/>
      <end position="174"/>
    </location>
  </feature>
  <feature type="helix" evidence="37">
    <location>
      <begin position="180"/>
      <end position="193"/>
    </location>
  </feature>
  <feature type="helix" evidence="37">
    <location>
      <begin position="203"/>
      <end position="206"/>
    </location>
  </feature>
  <feature type="helix" evidence="37">
    <location>
      <begin position="208"/>
      <end position="219"/>
    </location>
  </feature>
  <feature type="strand" evidence="38">
    <location>
      <begin position="223"/>
      <end position="225"/>
    </location>
  </feature>
  <feature type="helix" evidence="37">
    <location>
      <begin position="230"/>
      <end position="242"/>
    </location>
  </feature>
  <feature type="helix" evidence="37">
    <location>
      <begin position="245"/>
      <end position="247"/>
    </location>
  </feature>
  <feature type="helix" evidence="39">
    <location>
      <begin position="364"/>
      <end position="366"/>
    </location>
  </feature>
  <feature type="strand" evidence="39">
    <location>
      <begin position="368"/>
      <end position="371"/>
    </location>
  </feature>
  <evidence type="ECO:0000250" key="1">
    <source>
      <dbReference type="UniProtKB" id="Q60865"/>
    </source>
  </evidence>
  <evidence type="ECO:0000255" key="2"/>
  <evidence type="ECO:0000256" key="3">
    <source>
      <dbReference type="SAM" id="MobiDB-lite"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="4">
    <source>
      <dbReference type="PubMed" id="14764709"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="5">
    <source>
      <dbReference type="PubMed" id="17210633"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="6">
    <source>
      <dbReference type="PubMed" id="21933836"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="7">
    <source>
      <dbReference type="PubMed" id="22967762"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="8">
    <source>
      <dbReference type="PubMed" id="23097442"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="9">
    <source>
      <dbReference type="PubMed" id="27022092"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="10">
    <source>
      <dbReference type="PubMed" id="28592527"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="11">
    <source>
      <dbReference type="PubMed" id="28733330"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="12">
    <source>
      <dbReference type="PubMed" id="28794026"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="13">
    <source>
      <dbReference type="PubMed" id="30258011"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="14">
    <source>
      <dbReference type="PubMed" id="31439799"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="15">
    <source>
      <dbReference type="PubMed" id="32302570"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="16">
    <source>
      <dbReference type="PubMed" id="32302571"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="17">
    <source>
      <dbReference type="PubMed" id="32302572"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="18">
    <source>
      <dbReference type="PubMed" id="34074792"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="19">
    <source>
      <dbReference type="PubMed" id="35977029"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="20">
    <source>
      <dbReference type="PubMed" id="35979925"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="21">
    <source>
      <dbReference type="PubMed" id="36040869"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="22">
    <source>
      <dbReference type="PubMed" id="36136249"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="23">
    <source>
      <dbReference type="PubMed" id="36183834"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="24">
    <source>
      <dbReference type="PubMed" id="36279435"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="25">
    <source>
      <dbReference type="PubMed" id="7657653"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="26">
    <source>
      <dbReference type="PubMed" id="17210633"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="27">
    <source>
      <dbReference type="PubMed" id="31439799"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="28">
    <source>
      <dbReference type="PubMed" id="7657653"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="29"/>
  <evidence type="ECO:0000305" key="30">
    <source>
      <dbReference type="PubMed" id="7657653"/>
    </source>
  </evidence>
  <evidence type="ECO:0000312" key="31">
    <source>
      <dbReference type="HGNC" id="HGNC:6743"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="32">
    <source>
      <dbReference type="PubMed" id="20068231"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="33">
    <source>
      <dbReference type="PubMed" id="21406692"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="34">
    <source>
      <dbReference type="PubMed" id="23186163"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="35">
    <source>
      <dbReference type="PubMed" id="24129315"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="36">
    <source>
      <dbReference type="PubMed" id="24275569"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="37">
    <source>
      <dbReference type="PDB" id="4WBE"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="38">
    <source>
      <dbReference type="PDB" id="4WBP"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="39">
    <source>
      <dbReference type="PDB" id="6TA7"/>
    </source>
  </evidence>
  <sequence length="709" mass="78366" checksum="56F5BC188CA3A2D4" modified="2008-04-08" version="2">MPSATSHSGSGSKSSGPPPPSGSSGSEAAAGAGAAAPASQHPATGTGAVQTEAMKQILGVIDKKLRNLEKKKGKLDDYQERMNKGERLNQDQLDAVSKYQEVTNNLEFAKELQRSFMALSQDIQKTIKKTARREQLMREEAEQKRLKTVLELQYVLDKLGDDEVRTDLKQGLNGVPILSEEELSLLDEFYKLVDPERDMSLRLNEQYEHASIHLWDLLEGKEKPVCGTTYKVLKEIVERVFQSNYFDSTHNHQNGLCEEEEAASAPAVEDQVPEAEPEPAEEYTEQSEVESTEYVNRQFMAETQFTSGEKEQVDEWTVETVEVVNSLQQQPQAASPSVPEPHSLTPVAQADPLVRRQRVQDLMAQMQGPYNFIQDSMLDFENQTLDPAIVSAQPMNPTQNMDMPQLVCPPVHSESRLAQPNQVPVQPEATQVPLVSSTSEGYTASQPLYQPSHATEQRPQKEPIDQIQATISLNTDQTTASSSLPAASQPQVFQAGTSKPLHSSGINVNAAPFQSMQTVFNMNAPVPPVNEPETLKQQNQYQASYNQSFSSQPHQVEQTELQQEQLQTVVGTYHGSPDQSHQVTGNHQQPPQQNTGFPRSNQPYYNSRGVSRGGSRGARGLMNGYRGPANGFRGGYDGYRPSFSNTPNSGYTQSQFSAPRDYSGYQRDGYQQNFKRGSGQSGPRGAPRGRGGPPRPNRGMPQMNTQQVN</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>